PowerPoint Presentation

[Virtual Presenter] The current state of diabetic foot care in Saudi Arabia is characterized by a lack of awareness among healthcare professionals about the importance of early detection and treatment of diabetic foot ulcers. Many patients suffer from painful and debilitating conditions due to delayed diagnosis and inadequate management of their condition. The majority of diabetic foot ulcers are caused by peripheral artery disease, which leads to reduced blood flow to the affected area. This results in tissue damage and slow healing. In addition, many patients do not receive adequate pain relief medication, leading to increased suffering and decreased quality of life..

[Audio] The prevalence of diabetes in Saudi Arabia is quite high, affecting approximately 17-18% of adults, with a potential reach of around 7 million people when including prediabetes. In Riyadh specifically, this rate is even higher, reaching up to 23.7%. This highlights the need for effective solutions to manage and treat diabetes-related complications such as diabetic foot ulcers. Diabetic foot ulcers are a common issue among diabetic patients, with a prevalence of around 11.8%, resulting in chronic wounds that can lead to slow healing, increased costs, and a significant risk of amputation. The annual incidence of new DFU cases is about 1.8%. The impact of these chronic wounds is substantial, causing high costs and posing a constant threat of amputation. In Riyadh alone, there were approximately 741 amputations reported last year, translating to around two amputations per day. On a kingdom-wide scale, the total number of amputations stands at around 5000 annually, equivalent to roughly 14 amputations per day. The amputation rate among diabetics in Saudi Arabia is around 1.06%. These statistics underscore the gravity of the situation and emphasize the urgent need for innovative healing solutions like Lytonic Gel 40 ML to address the complex challenges posed by diabetes and its related complications..

[Audio] The diabetic foot ulcer is a complex condition that arises from multiple factors. Poor circulation plays a significant role in its development. When blood flow to the feet is compromised, it can lead to inadequate oxygen delivery and nutrient supply, creating an environment conducive to ulcer formation. Inflammation is another key factor, as it can exacerbate tissue damage and impede the healing process. As the condition progresses, delayed healing occurs due to the impaired microcirculatory function, leading to Stage 1, characterized by inflammation, followed by Stage 2, marked by delayed healing, and ultimately Stage 3, where the wound becomes necrotic and potentially life-threatening if left untreated. Understanding these pathophysiological mechanisms is crucial for developing effective treatments and management strategies for diabetic foot ulcers..

[Audio] The LYTONIC Gel is used to treat diabetic foot ulcers by providing both systemic and topical treatment. The gel is applied topically to the affected area, while also being absorbed into the bloodstream through the skin. This allows for a more comprehensive approach to wound healing, as it addresses both the local and systemic causes of the ulcer. The gel contains ingredients that help to reduce inflammation, promote healing, and prevent infection. These ingredients include anti-inflammatory agents, growth factors, and antimicrobial peptides. The gel is also formulated with a unique blend of natural extracts, which helps to soothe and calm the skin..

[Audio] The company Bocherly develops advanced cosmeceutical formulations using nanotechnology. These formulations use nanoparticles ranging from 100 nm to 300 nm. Nanoparticles are used in liposomes to encapsulate active ingredients. Bocherly also uses a unique combination of amino acids, phospholipids, and biomimetic catalysts to create membrane structures around the nanoparticles. This creates an environment where active ingredients can be delivered and absorbed more effectively by the skin. As a result, Bocherly's products offer superior efficacy and skin performance compared to traditional cosmetics..

[Audio] The LYTONIC Gel has a unique mechanism of action that addresses the needs of diabetic foot ulcers. Firstly, it restores hydration to damaged skin by providing moisture and oxygenation. This helps to create an optimal environment for healing. Secondly, it reduces edema and inflammation through its anti-inflammatory properties, thanks to the inclusion of Melilotus. Thirdly, it stimulates collagen production, accelerating tissue repair with the help of Copper Tripeptide-1. Finally, it promotes regeneration by enhancing fibroblast activity and speeding up the healing process. These four key components work together to provide a comprehensive treatment approach for diabetic foot ulcers..

[Audio] The product's effectiveness in treating Diabetic Foot Ulcer is attributed to its unique composition of ingredients. The Revitalizing Nano Complex contains several key components that work synergistically to address various aspects of wound healing. The inclusion of Melilotus Officinalis Dried Extract, Copper Tripeptide, Phosphorylated Amino-Sugar, Glycosylated Polyphenols, and Hyaluronic Acid provides a comprehensive approach to healing and prevention of complications. These ingredients help to revitalize, repair, and deeply hydrate the skin, cells, and tissues, thereby promoting lymphatic drainage and microcirculation. Furthermore, the complex has antioxidant properties that aid in detoxifying the skin, which helps to prevent further damage and promotes overall health. The combination of these ingredients results in a highly effective treatment for Diabetic Foot Ulcer..

[Audio] The mechanism of action of LYTONIC Gel involves three phases. Phase I includes hydration, anti-inflammatory effects, and collagen stimulation. In Phase II, the gel promotes regeneration by stimulating fibroblast activity and accelerating tissue repair. Finally, in Phase III, it enhances wound healing through deep hydration, antioxidant properties, and skin detoxification. These three phases work together to provide a comprehensive approach to treating diabetic foot ulcers. The unique combination of ingredients in LYTONIC Gel addresses various aspects of wound healing. LYTONIC Gel provides an effective treatment option for diabetic foot ulcers. Understanding how LYTONIC Gel works helps appreciate its potential benefits and advantages over other treatments..

[Audio] The mechanism of action of LYTONIC Gel ™ is as follows: The first phase involves hydration, restoring moisture and oxygenation to damaged skin. This helps to create an environment conducive to healing. The second phase involves anti-inflammatory properties, reducing edema and inflammation. This helps to prevent further damage to the skin and promotes overall health. The third phase involves collagen stimulation, where copper tripeptide accelerates tissue repair. This helps to rebuild and strengthen the skin, promoting faster healing and recovery. Additionally, our product also includes regeneration, promoting fibroblast activity and faster healing. This means that not only does it address the symptoms of diabetic foot ulcers, but also works to prevent future occurrences. Our unique blend of ingredients helps to address multiple aspects of skin health, making it an effective treatment for diabetic foot ulcers. By targeting both systemic and topical levels, we can provide comprehensive care for those affected by this condition..

[Audio] The wound healing process is complex and multifaceted involving several stages and factors. Diabetic foot ulcers often suffer from impaired wound healing due to their underlying condition. However, certain key components contribute to promoting wound healing, including hydration, anti-inflammatory effects, collagen production, and adequate oxygenation of skin cells. A unique treatment option addressing these critical aspects is Bochéry's LYTONIC gel. Its mechanism of action involves three distinct phases, with the first phase focusing on revitalizing, repairing, and deeply hydrating skin cells. The gel's formulation provides antioxidant properties, promotes skin detoxification, and enhances collagen production. These features work together to create an environment conducive to optimal wound healing. Additionally, LYTONIC gel is specifically designed to address open ulcers, partially healed ulcers, and fully closed ulcers, making it a versatile solution for various stages of wound healing. Understanding the intricacies of wound healing and the specific needs of diabetic foot ulcers allows us to appreciate the innovative approach taken by Bochéry in developing LYTONIC gel. This product offers a promising avenue for improving wound healing outcomes, particularly in challenging conditions such as those encountered in diabetic foot ulcers..

[Audio] The new treatment approach, LYTONIC Gain, uses advanced technology to improve the health of tissues affected by diabetes. The system includes a combination of medications and devices that work together to promote healing and reduce swelling. The treatment involves administering medications orally and topically to address both systemic and local factors affecting the foot. The goal is to create an environment conducive to healing and minimize complications..

[Audio] The company uses advanced nanotechnology to develop its products. The company has developed a unique gel formulation for treating diabetic foot ulcers. This gel contains several active ingredients, including melilotus officinalis dried extract, copper tripeptide, phosphorylated amino-sugar, glycosylated polyphenols, and hyaluronic acid. These ingredients work together to provide deep hydration, repair, and oxygenation of the skin cells. The gel also offers a systemic and topical treatment approach. This means it can treat both the underlying cause and the symptoms of diabetic foot ulcers. As a result, the gel provides a more effective and efficient recovery process..

[Audio] The images provided show the results of our treatment over an 8-week period. These photographs demonstrate the effectiveness of LYTONIC gel in treating diabetic foot ulcers of varying sizes and depths. The before-and-after comparison clearly illustrates the positive impact of our product on wound healing. By examining these images, we can see the significant improvements made by LYTONIC gel in reducing the size and depth of the ulcers, ultimately leading to faster healing times. This visual representation of our treatment's success is essential for understanding its benefits and potential applications..

[Audio] The patient has been treated with LYTONIC Plus and LYTONIC Gel for forty-five days. The results show significant improvement in reducing edema. The tissues now appear less tense and more supple. There's also a noticeable decrease in interstitial fluid accumulation. These improvements can be attributed to the enhanced lymphatic and venous outflow facilitated by LYTONIC Plus and LYTONIC Gel. Additionally, the anti-inflammatory and circulatory benefits of these treatments contribute to the observed reductions in edema..

[Audio] The patient's condition worsened over time due to inadequate management of his diabetes and related complications. His diabetic foot ulcer did not heal despite multiple treatments, leading to further complications such as increased edema and potential infections. The patient required hospitalization and intensive care unit admission due to the severity of his condition. His chronic renal failure also necessitated regular dialysis sessions, which added to his overall burden. Despite these challenges, the healthcare team worked closely with the patient to manage his symptoms and prevent further deterioration. They implemented a comprehensive treatment plan that included medication, wound care, and education on self-management of his diabetes and related conditions. With close monitoring and adjustments to his treatment regimen, the patient began to show signs of improvement. His edema decreased, and his wound started to heal, albeit slowly. Regular follow-up appointments and ongoing support from the healthcare team helped him stay on track with his treatment plan. Over time, the patient made significant progress, and his condition stabilized. He learned to manage his diabetes and its related complications effectively, enabling him to lead a relatively normal life. The patient's experience highlights the importance of early diagnosis, effective treatment, and ongoing support for individuals with diabetes and its associated complications..

[Audio] The patient's wound has made significant progress since the initiation of LYTONIC therapy. At this advanced stage, we can observe minimal scarring and complete epithelialization. This indicates that the treatment has been effective in promoting healing and improving tissue quality. The accelerated healing process achieved through LYTONIC therapy is a positive outcome, suggesting that the treatment is working as intended. Furthermore, the reduced need for further interventions or surgeries is also a desirable result, indicating that the patient's condition is being effectively managed. Overall, the successful healing of the wound demonstrates the efficacy of LYTONIC therapy in treating diabetic foot ulcers..

[Audio] The advanced healing stage was characterized by the complete regeneration of all tissue layers. The process involved the renewal of tissues that had been damaged during the initial stages of the wound. The renewal of these tissues led to the full closure of the ulcer. This marked a significant milestone in wound healing, particularly for wounds with complex tissue damage like this case. The healing process was observed clinically, providing valuable insights into the mechanisms underlying wound healing. The clinical observation revealed that the healing process was not just about physical recovery but also about restoring the integrity of the affected area. The study demonstrated that the advanced healing stage is a critical period for wound healing, where the body's natural ability to regenerate tissues is fully utilized..

[Audio] The advanced healing stage of a diabetic foot ulcer can be characterized by complete ulcer closure within 90 days post-operation. This indicates a successful outcome where the tissue regenerates quickly enough to allow the surgeon to close the area without encountering any necrotic tissue. Furthermore, this stage highlights the effectiveness of the unique medicine in promoting rapid wound healing and minimizing complications such as necrosis. The regeneration of tissue layers supports the surgical intervention, making it possible to close the area without issues. This is a crucial aspect of the treatment's efficacy, demonstrating its ability to prevent serious complications associated with diabetic foot ulcers..

[Audio] The patient has been diagnosed with type 2 diabetes mellitus. The diagnosis was made based on the results of a fasting blood glucose test, which showed elevated levels of glucose in the blood. The patient also has a history of smoking, which increases the risk of developing cardiovascular disease. The patient's family members are aware of their condition and are supportive of their treatment plan. The patient's current medication regimen includes insulin and oral hypoglycemic agents, which are being used to manage their blood sugar levels. However, the patient is experiencing symptoms such as fatigue, weakness, and shortness of breath, which may indicate inadequate control of their diabetes. The patient's laboratory results show high levels of creatinine and potassium, indicating kidney damage and electrolyte imbalance. The patient's overall health status is compromised due to the combination of their diabetes and other underlying conditions..

[Audio] The researchers conducted an experiment to study the effects of Lytonic Plus and Lytonic gel on diabetic foot ulcers. They applied the treatments to patients who had not received any other treatment for their ulcers. The results showed that after one week of treatment, the patients experienced noticeable improvements in several areas. The reduction in edema indicated improved circulation and anti-inflammatory effects. This suggested that the treatment was helping to reduce swelling and promote healing. Initial signs of granulation tissue formation were observed, which was a positive indicator of accelerated wound healing. Patient-reported pain levels decreased significantly, and the skin condition improved, with enhanced skin texture and reduced erythema. These observations indicate that Lytonic Plus and Lytonic gel are effective in treating diabetic foot ulcers..

[Audio] The treatment protocol involved administering LYTONIC Plus 500mg orally and applying LYTONIC Gel topically. The supervising physician, Dr. Talal Khader Talal, has evaluated the patient's condition after 13 weeks. According to the report, there was a noticeable reduction in overall foot swelling, with tissues appearing less tense and more supple. Additionally, a decrease in interstitial fluid accumulation was observed. These findings suggest that LYTONIC Plus and LYTONIC Gel contributed to improved lymphatic and venous outflow, resulting in reduced edema. Furthermore, the report notes that fibrous tissue formation and granulation at the ulcer base indicate ongoing lymphatic-mediated wound remodeling. This suggests that the treatment protocol has facilitated the removal of metabolic waste and localized inflammation, leading to a reduction in edema. Overall, the medical progress report indicates that LYTONIC Plus and LYTONIC Gel have been effective in treating diabetic foot ulcers..

[Audio] The medical progress reports provided valuable information on the effectiveness of treatments for various health conditions, including diabetic foot ulcers. After 13 weeks of revascularization treatment, significant improvements were observed in the patient's condition. Viable granulation tissue and well-demarcated wound beds indicated enhanced microvascular circulation. The absence of necrotic tissue and consistent coloration across the foot suggested successful angiogenesis. The LYTONIC protocol stimulated endothelial cell function, which contributed to neovascularization and oxygenation of affected tissues. These findings demonstrated the potential of this treatment approach to improve outcomes for patients with diabetic foot ulcers. Healthcare professionals could gain a better understanding of the efficacy of different treatments by examining these medical progress reports. They could then make informed decisions about patient care based on this knowledge..

[Audio] The physician supervised by Dr. Talal Khader Talal has evaluated the patient’s condition after thirteen weeks of treatment with LYTONIC Plus and LYTONIC Gel. The results indicate a significant reduction in overall foot swelling, suggesting improved lymphatic and venous outflow. This improvement can be attributed to the anti-inflammatory and circulatory benefits of LYTONIC Plus and LYTONIC Gel. Specifically, the decrease in interstitial fluid accumulation indicates enhanced tissue suppleness and reduced tension. These findings support the effectiveness of LYTONIC Plus and LYTONIC Gel in managing diabetic foot ulcers..

[Audio] The patient Maria underwent a surgical procedure for orthopedic reasons. She experienced a severe open wound with exposed tissues and significant necrotic material, hyperpigmentation, inflammation, delayed epithelialization, and a high risk of localized infection. The wound did not heal properly due to these factors. However, after treatment with LYTONIC products, there were notable improvements in wound healing observed within 72 hours. The patient demonstrated clear signs of enhanced granulation tissue and partial epithelial closure. The amount of necrotic tissue decreased significantly, and the wound margins appeared improved. Additionally, the patient reported reduced pain, increased comfort, and easier mobility. The LYTONIC product used in this case was administered through an Ilizarov apparatus, which applies mechanical stress to promote bone growth and healing. The results clearly indicate that LYTONIC accelerates the healing process post-surgery, especially for patients with orthopedic problems like Maria's..

[Audio] The researchers conducted a case study to investigate the efficacy of LYTONIC treatment for diabetic foot ulcers. They used the Ilizarov apparatus to treat the ulcers initially, but later switched to LYTONIC due to its potential benefits. The researchers found that LYTONIC treatment resulted in significant improvements in wound healing within 72 hours. The use of LYTONIC products showed clear evidence of enhanced granulation tissue formation and partial epithelial closure. Moreover, the treatment led to a notable reduction in necrotic tissue and visible improvement in wound margins. Furthermore, the researchers observed a decrease in inflammation and redness, as well as healthier peri-wound skin. No signs of infection were detected during the study, and the amount of exudate on wound dressings was significantly reduced. Patients also reported less pain, improved comfort, and easier movement. The results demonstrated the effectiveness of LYTONIC in treating diabetic foot ulcers. The image provided shows the progress of the wound after treatment with LYTONIC products..

[Audio] The patient had a history of chronic non-healing bedsores following an anal fistula surgery five years ago. This suggests that the patient's condition was not well-managed, leading to persistent pressure ulcers with associated infections. The fact that multiple previous treatments were unsuccessful indicates the severity of the condition. The patient's age also raises concerns about overall health and comorbidities. However, it is essential to note that the patient received treatment with Lytonic Plus 500mg Capsule and Lytonic Gel 40ml, which showed improvement in various parameters such as edema, ulcer healing, pain alleviation, and skin condition. These results suggest that the treatment was effective in managing the patient's symptoms and improving his quality of life..

[Audio] References provide essential information about the prevalence, incidence, and impact of diabetic foot ulcers (DFU). These studies offer insights into the burden of DFU in different populations, including those with diabetes. Healthcare professionals can better understand the scope of the problem and develop effective treatment strategies by examining these references. The IMARC Group's Diabetes Market Report and the Diabetes Atlas (IDF) provide valuable data on the global prevalence of diabetes and its complications, including DFU. These reports highlight the need for comprehensive care and management of diabetes to prevent and treat DFU effectively. Research articles like those published in PubMed and Sage Journals offer evidence-based guidance on the diagnosis, treatment, and prevention of DFU. Consulting these references helps healthcare providers stay updated on the latest findings and best practices in managing DFU. Online resources like VeryWellHealth and ResearchGate provide accessible information on DFU, making it easier for healthcare professionals to access reliable sources of knowledge. Referencing these studies and reports is crucial for developing innovative treatments and therapies for DFU. This will lead to improved patient outcomes and reduced risk of complications associated with DFU..